1. Home
  2. Animal Drug Index - F
  3. Fumagilin-b

Animal NDC 86196-001-45 Fumagilin-b

Fumagillin Dicyclohexylamine

Animal Product Information

Field Name Field Value
Animal NDC Code 86196-001-45
Proprietary Name Fumagilin-b What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Fumagillin Dicyclohexylamine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Vita Bee Health Canada Ltd
Product Type Otc Animal Drug
Usage Information
    As an aid in the prevention of Nosema in honey bees.
Active Ingredient(s)
  • Bicyclohexylammonium Fumagillin
Marketing Category UNAPPROVED DRUG OTHER What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Fumagilin-b Images

Fumagilin-b Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Active Ingredients:



 21 mg fumagillin base (as fumagillin dicyclohexylamine) per g of powder.


Indications:



As an aid in the prevention of Nosema in honey bees.


Directions For Use:



This jar contains the equivalent of 0.5 g Fumagillin base which is sufficient to prepare 20 Litres of medicated syrup for feeding of 5-6 package colonies or for fall feeding of 3 wintering colonies.

This jar contains the equivalent of 2.0 g Fumagillin base which is sufficient to prepare 80 Litres of medicated syrup for feeding of 22 package colonies or for fall feeding of 12 wintering colonies.

This jar contains the equivalent of 9.5 g Fumagillin base which is sufficient to prepare 380 Litres of medicated syrup for feeding of 100-110 package colonies or for fall feeding of 50 wintering colonies.

Consult package insert for detailed directions for the preparation of the medicated syrup and dosage instructions.

Mixing and Feeding Instructions in U.S. Measurements
Preparation of Medicated Syrup:

 Water + Sugar = Syrup+ Fumagilin-B 
 44 gallons+ 727 lbs. = 100 gallons + 16 ounces (454 g bottle) 
 9½ gallons + 152 lbs.= 21 gallons + 3.4 ounces (96 g bottle) 
 2¾ gallons + 37 lbs. = 5.2 gallons+ 0.85 ounces (24 g bottle) 
 ½ Gallon + 8 lbs. = 1 gallon0.18 ounces
(5 g = ½ rounded tablespoon) 

Fall Feeding Medicated Syrup

2 gallons for each 2-chamber colony (approx. 30,000 bees)
1 gallon for each 1-chamber colony (approx. 18,000 bees)
3/4 gallon for each 5-frame colony (approx. 12,000 bees)

Feed additional unmedicated syrup to desired colony weight for wintering.

Spring Feeding Medicated Syrup

1 gallon for each 2-chamber colony (approx. 20,000 bees)
½ gallon for each 1-chamber colony (approx. 12,000 bees)
½ gallon for each 5-frame colony (approx. 8,000 bees)
1 gallon for each package colony.

Feed additional unmedicated syrup to provide nourishment until nectar is available.

Additional Measurements (approximate)
½ teaspoon = 1.5 g Fumagilin-B (31.5 mg activity)
1 teaspoon = 3.0 g Fumagilin-B (63 mg activity)
½ tablespoon = 5.0 g Fumagilin-B (100 mg activity)
1 tablespoon = 9.5 g Fumagilin-B (200 mg activity)
2/3 cup = 50 g Fumagilin-B (1.05 g activity)


Storage:



Store below 25˚C, protected from sunlight. Keep from freezing. Once mixed, do not expose medicated syrup to sunlight.


Packaging




* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.